A Case of Pseudohypoparathyroidism Type Ib Caused by Aberrant Methylation in the GNAS Complex Locus
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Pseudohypoparathyroidism (PHP) is a rare disorder caused by genetic and epigenetic aberrations in the GNAS complex locus resulting in impaired expression of stimulatory G protein (Gsα). PHP type Ib (PHP-Ib) is characterized by hypocalcemia and hyperphosphatemia due to renal resistance to the parathyroid hormone, and is distinguished from PHP-Ia by the absence of osteodystrophic features. An 11-yr-old boy presented with poor oral intake and cramping lower limb pain after physical activity. Laboratory studies revealed hypocalcemia, hyperphosphatemia, and increased parathyroid hormone levels. The GNAS complex locus was evaluated using the methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) assay. Gain of methylation in the NESP55 domain and loss of methylation in the antisense (AS) transcript, XL, and A/B domains in the maternal allele were observed. Consequently, we present a case of PHP-Ib diagnosed using MS-MLPA.
Abstract
Pseudohypoparathyroidism (PHP) is a rare disorder caused by genetic and epigenetic aberrations in the GNAS complex locus resulting in impaired expression of stimulatory G protein (Gsα). PHP type Ib (PHP-Ib) is characterized by hypocalcemia and hyperphosphatemia due to renal resistance to the parathyroid hormone, and is distinguished from PHP-Ia by the absence of osteodystrophic features. An 11-yr-old boy presented with poor oral intake and cramping lower limb pain after physical activity. Laboratory studies revealed hypocalcemia, hyperphosphatemia, and increased parathyroid hormone levels. The GNAS complex locus was evaluated using the methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) assay. Gain of methylation in the NESP55 domain and loss of methylation in the antisense (AS) transcript, XL, and A/B domains in the maternal allele were observed. Consequently, we present a case of PHP-Ib diagnosed using MS-MLPA.
참고문헌 (20)
- Mantovani G, "Clinical review : Pseudohypoparathyroidism : diagnosis and treatment", J Clin Endocrinol Metab, 96, pp.3020~3030 (2011)
- Drezner M, "Pseudohypoparathyroidism type II : a possible defect in the reception of the cyclic AMP signal", N Engl J Med, 289, pp.1056~1060 (1973)
- Bastepe M, "The GNAS Locus: Quintessential complex gene encoding Gsalpha, XLalphas, and other imprinted transcripts", Curr Genomics, 8, pp.398~414 (2007)
- Yuno A, "Genetic and epigenetic states of the GNAS complex in pseudohypoparathyroidism type Ib using methylation-specific multiplex ligation-dependent probe amplification assay", Eur J Endocrinol, 168, pp.169~175 (2013)
- Bastepe M, "Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS", J Clin Invest, 112, pp.1255~1263 (2003)
- Linglart A, "Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus", Clin Endocrinol, 67, pp.822~831 (2007)
- Liu J, "Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB", Hum Mol Genet, 14, pp.95~102 (2005)
- Mantovani G, "Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib", J Clin Endocrinol Metab, 92, pp.3738~3742 (2007)
- Bastepe M, "Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A", B : evidence for a long-range regulatory element within the imprinted GNAS1 locus, 2001, pp.10, 1231~1241
- Liu J, "A GNAS1 imprinting defect in pseudohypoparathyroidism type IB", J Clin Invest, 106, pp.1167~1174 (2000)
- Linglart A, "Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus", Clin Endocrinol, 67, pp.822~831 (2007)
- Kidd GS, "Skeletal responsiveness in pseudohypoparathyroidism : a spectrum of clinical disease", Am J Med, 68, pp.772~781 (1980)
- Murray TM, "Pseudohypoparathyroidism with osteitis fibrosa cystica : direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone", J Bone Miner Res, 8, pp.83~91 (1993)
- Balkissoon AR, "Case 14 : intramedullary osteosclerosis", Radiology, 212, pp.708~710 (1999)
- Sbrocchi AM, "Osteosclerosis in two brothers with autosomal dominant pseudohypoparathyroidism type 1b : bone histomorphometric analysis", Eur J Endocrinol, 164, pp.295~301 (2011)
- Bastepe M, "Paternal uniparental isodisomy of the entire chromosome 20 as a molecular cause of pseudohypoparathyroidism type Ib(PHP-Ib)", Bone, 48, pp.659~662 (2011)
- Bastepe M, "Paternal uniparental isodisomy of chromosome 20q--and the resulting changes in GNAS1 methylation--as a plausible cause of pseudohypoparathyroidism", Am J Hum Genet, 68, pp.1283~1289 (2001)
- Dixit A, "Pseudohypoparathyroidism type 1b due to paternal uniparental disomy of chromosome 20q", J Clin Endocrinol Metab, 98, pp.E103~E108 (2013)
- Garin I, "European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS : an EQA study", Eur J Hum Genet, 23, pp.438~444 (2015)
- Cho SY, "Clinical characterization and molecular classification of 12 Korean patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism", Exp Clin Endocrinol Diabete, 121, pp.539~545 (2013)